Join to View Full Profile
Dana-Farber Cancer Institute450 Brookline AveBoston, MA 02215
Phone+1 617-632-3468
Fax+1 617-632-5786
Dr. Jackman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2003 - 2006
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2003
The Warren Alpert Medical School of Brown UniversityClass of 2000
Certifications & Licensure
FL State Medical License 2023 - Present
ME State Medical License Current
NH State Medical License 2009 - 2026
RI State Medical License 2023 - 2026
VT State Medical License 2023 - 2026
CT State Medical License 2023 - 2025
MA State Medical License 2004 - 2025
American Board of Internal Medicine Medical Oncology- Join now to see all
Clinical Trials
- Erlotinib Therapy and Subsequent Development of Mechanisms of Secondary Resistance in Patients With NSCLC Start of enrollment: 2010 Feb 01
- Window of Opportunity Study of VS-6063 (Defactinib) in Surgical Resectable Malignant Pleural Mesothelioma Participants Start of enrollment: 2013 Dec 12
- Study of the EZH2 Inhibitor Tazemetostat in Malignant Mesothelioma Start of enrollment: 2016 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Phase II Study of Defactinib (VS6063) in Patients With Tumors WithLoss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U.Marjorie G Zauderer, Opeyemi Jegede, David M Jackman, James A Zwiebel, Robert J Gray
JCO Precision Oncology. 2024-12-01 - 1 citationsUsing Oncology Treatment Pathway Data to Evaluate Serious Illness Communication, Care Utilization, and End-of-Life Care for Patients With Cancer.Cody E Cotner, Angela C Tramontano, Alex Post, Brian Finn, Saima Awan
JCO Oncology Practice. 2024-09-30 - 3 citationsEarly Findings on the Use of Clinical Pathways for Management of Unwarranted Variation in Cancer Care.David M. Jackman, Emily Foster, Joanna M. Hamilton, Carole Kathleen Tremonti, Craig A. Bunnell
American Journal of Medical Quality. 2021-06-08
Press Mentions
Cancer Without Chemotherapy: ‘A Totally Different World’September 27th, 2021
What Mesothelioma Awareness Day Means to a SurvivorSeptember 26th, 2019
Royal Philips : Philips IntelliSpace Precision Medicine Oncology Pathways Powered by Dana-Farber Is Now LiveSeptember 11th, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
